While physiological cardiac hypertrophy can be observed during development, exercise, and pregnancy, pathological cardiac hypertrophy responds to hemodynamic stress conditions like arterial hypertension, valvular heart disease, or gene mutations. Initially, the heart undergoes a remodeling characterized by increased cardiomyocyte size and thickening of the ventricular walls to maintain cardiac function1,2. On the other hand, pathological cardiac remodeling is associated with an increased risk for arrhythmia, sudden death, and high mortality. Finally, with time, it results in ventricular dilation, a strong decrease in contractile function, and eventual progression to heart failure (HF), which is associated with high morbidity, mortality, and societal costs3. Therefore, there is an urgent need to understand the molecular background in order to develop new therapeutic strategies4.
Aortic banding is a model that mimics pressure overload-induced left ventricular (LV) hypertrophy and heart failure in mice5. With this method, it is possible to examine the pathomechanisms of pressure overload-induced cardiac remodeling in vivo. The first aortic banding procedure in mice was reported by Rockman et al.6. Pressure overload is induced by a thread suture-based ligation around the aorta (between the brachiocephalic and left common carotid artery). To create a 0.4 mm diameter stenosis, a suture is placed around a 27 G needle and the aorta. After ligation, the needle is removed6,7.
Even though the needle diameter is fixed, the tightness of the thread is highly dependent on the surgeon and, therefore, affects the induced phenotype of cardiac hypertrophy. In addition, in the thread/suture-based method, there is a variable degree of stenosis diameter after surgery, associated with a high variance in mortality8,9. Moreover, training this method is challenging, especially regarding finding the right level and consistency in tightening the thread. Finally, at the beginning of training, high intra- and post-operative mortality due to disruption of the aorta or other tissue injury occurs, as well as high variation in the extent of stenosis in the surviving animals.
Recently, an optimized procedure of aortic banding was described by Melleby et al.10. They presented the ORAB (o-ring aortic banding) method with less variance in stenosis and highly reproducible levels of pressure overload by using a non-slip rubber o-ring with a fixed inner diameter of 0.71 mm, 0.66 mm, and 0.61 mm. In short, the o-ring is cut open, placed around the ascending arch, and closed again by threads. Other scientists using these o-rings reported less variability in the induced cardiac hypertrophy9. They also observed intra- and post-operative mortality, as well as better reproducibility and less variance in the induced hypertrophic phenotype9,11. The present article describes the procedure of this unique strategy in a step-by-step protocol. The expertise shared in this report will help other scientists to improve their techniques in this area.
To induce cardiac hypertrophy resulting in heart failure after 6 weeks, 12-week-old C57BL/6N male mice are recommended for surgery. A comparison 2 weeks after aortic banding between the mouse substrains C57BL/6N and C57BL/6J showed severe cardiac dysfunction and associated increased mortality in C57BL/6N mice. Therefore, these are better suited for models of heart failure12. Twelve-week-old male and female mice have an optimal size for exposure of the aorta and placement of the o-ring with special instruments.